AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
Log in

ASX:MDRMedadvisor Stock Price, Forecast & News

A$0.52
+0.02 (+3.96 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.50
Now: A$0.53
A$0.53
50-Day Range
A$0.38
MA: A$0.47
A$0.58
52-Week Range
A$0.28
Now: A$0.53
A$0.61
Volume719,064 shs
Average VolumeN/A
Market Capitalization$129.12 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAdvisor Limited develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and Web technologies; and PlusOne, a software platform, which allow pharmacies to connect with patients via SMS, App, Web/email or Landline. MedAdvisor Limited is based in Camberwell, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.80 million
Cash FlowA$0.07 per share
Book ValueA$0.08 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$129.12 million
Next Earnings DateN/A
OptionableOptionable

Receive MDR News and Ratings via Email

Sign-up to receive the latest news and ratings for MDR and its competitors with MarketBeat's FREE daily newsletter.

Medadvisor (ASX:MDR) Frequently Asked Questions

How has Medadvisor's stock been impacted by COVID-19 (Coronavirus)?

Medadvisor's stock was trading at A$0.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDR stock has increased by 25.0% and is now trading at A$0.53. View which stocks have been most impacted by Coronavirus.

Has Medadvisor been receiving favorable news coverage?

News stories about MDR stock have been trending extremely negative on Friday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medadvisor earned a media sentiment score of -4.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutMedadvisor.

Who are some of Medadvisor's key competitors?

Who are Medadvisor's key executives?

Medadvisor's management team includes the following people:
  • Mr. Robert Read BComm(Mgt), BA(Psych), GAICD, MD, CEO & Exec. Director
  • Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons)., Founder, Chief Product Officer & Exec. Director
  • Mr. Carlo Campiciano, Company Sec. & CFO
  • Mr. Victor Kovalev, CTO & Head of Product
  • Jennifer Duraisingam, Corp. Communications Mang.

What is Medadvisor's stock symbol?

Medadvisor trades on the ASX under the ticker symbol "MDR."

What is Medadvisor's stock price today?

One share of MDR stock can currently be purchased for approximately A$0.53.

How big of a company is Medadvisor?

Medadvisor has a market capitalization of $129.12 million and generates $8.80 million in revenue each year.

What is Medadvisor's official website?

The official website for Medadvisor is www.medadvisor.com.au.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.